Cargando…
Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Opioids are the most effective analgesics used in the clinical management of cancer pain or non-cancer pain. However, chronic opioids therapy can cause many side effects including respiratory depression, nausea, sedation, itch, constipation, analgesic tolerance, hyperalgesia, high addictive potentia...
Autores principales: | Zhang, Li, Zhang, Jiang-Tao, Hang, Lihua, Liu, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373791/ https://www.ncbi.nlm.nih.gov/pubmed/32760281 http://dx.doi.org/10.3389/fphar.2020.01078 |
Ejemplares similares
-
Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023) -
Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
por: Ugur, Muzeyyen, et al.
Publicado: (2018) -
Functional selectivity of EM-2 analogs at the mu-opioid receptor
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2023) -
Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimer
por: Reinecke, Bethany A., et al.
Publicado: (2019) -
It’s MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system
por: Chartoff, Elena H., et al.
Publicado: (2014)